These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
(Mark One)
|
|
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
Not Applicable
|
||||
|
(State or other jurisdiction
of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
||||
|
300 East Lombard Street,
Suite 1710
|
|||||
|
|
|
||||
|
|
|||||
|
(Zip Code)
|
|||||
|
(Address of principal executive office (US))
|
|||||
|
|
|
||||
|
(Registrant's telephone number, including area code)
|
|||||
|
Securities registered pursuant to section 12(b) of the Act
|
|||||
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|||
|
|
|
|
|||
|
|
x
|
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
|
|
Emerging growth company
|
|
|
Page
|
||
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 1B.
|
||
|
Item 1C.
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
Item 5.
|
||
|
Item 6.
|
||
|
Item 7.
|
||
|
Item 7A.
|
||
|
Item 8.
|
||
|
Item 9.
|
||
|
Item 9A.
|
||
|
Item 9B.
|
||
|
Item 9C.
|
||
|
Item 10.
|
||
|
Item 11.
|
||
|
Item 12.
|
||
|
Item 13.
|
||
|
Item 14.
|
||
|
Item 15.
|
||
|
Item 16.
|
||
|
Location
|
Country
|
Owned/Leased
|
||
|
Packaging & Automotive Rolled Products
|
||||
|
Biesheim, Neuf-Brisach
|
France
|
Owned
|
||
|
Singen
|
Germany
|
Owned
|
||
|
Muscle Shoals, AL
|
United States
|
Owned
|
||
|
Bowling Green, KY
|
United States
|
Owned
|
||
|
Aerospace & Transportation
|
||||
|
Issoire
|
France
|
Owned
|
||
|
Montreuil-Juigné
|
France
|
Owned
|
||
|
Ravenswood, WV
|
United States
|
Owned
|
||
|
Steg
|
Switzerland
|
Owned
|
||
|
Sierre
|
Switzerland
|
Owned
|
||
|
Automotive Structures & Industry
|
||||
|
Lakeshore, Ontario (JV)
(1)
|
Canada
|
Leased
|
||
|
Changchun, Jilin Province (JV)
(2)
|
China
|
Leased
|
||
|
Nanjing
|
China
|
Leased
|
||
|
Děčín
|
Czech Republic
|
Owned
(3)
|
||
|
Nuits-Saint-Georges
|
France
|
Owned
|
||
|
Neckarsulm
|
Germany
|
Owned
|
||
|
Gottmadingen
|
Germany
|
Leased
|
||
|
Singen
|
Germany
|
Owned
(3)
|
||
|
San Luis Potosi
|
Mexico
|
Leased
|
||
|
Levice
|
Slovakia
|
Owned/Leased
|
||
|
Zilina
|
Slovakia
|
Leased
|
||
|
Vigo
|
Spain
|
Leased
|
||
|
Chippis
|
Switzerland
|
Owned
|
||
|
Sierre
|
Switzerland
|
Owned
|
||
|
Van Buren, MI
|
United States
|
Leased
|
||
|
White, GA
|
United States
|
Leased
|
|
Period
|
Total number of
shares purchased
|
Average price paid
per share
|
Total number of
shares purchased
as part of publicly
announced
programs
|
Maximum
approximate dollar
value that may yet
be purchased
under the program
|
||||
|
October 1 - October 31, 2024
|
—
|
0
|
—
|
239,642,036
|
||||
|
November 1 - November 30, 2024
|
1,557,520
|
11.86
|
1,557,520
|
221,217,362
|
||||
|
December 1 - December 31, 2024
|
—
|
0
|
—
|
221,217,362
|
||||
|
Total
|
1,557,520
|
1,557,520
|
221,217,362
|
|
Year ended December 31, 2024
|
||||
|
(as a % of total)
|
Revenue
|
Segment
Adjusted
EBITDA
|
||
|
A&T
|
25
%
|
50
%
|
||
|
P&ARP
|
57
%
|
43
%
|
||
|
AS&I
|
20
%
|
13
%
|
||
|
Holdings and Corporate
|
—
%
|
(6)
%
|
||
|
Total
|
100
%
|
100
%
|
||
|
Year ended December 31,
|
Percent changes
|
|||||||||
|
(U.S. dollars per ton)
|
2024
|
2023
|
2022
|
2024 vs 2023
|
2023 vs 2022
|
|||||
|
Average LME
transaction price
|
2,419
|
2,250
|
2,708
|
8
%
|
(17)
%
|
|||||
|
Average Midwest premium
|
432
|
510
|
658
|
(15)
%
|
(22)
%
|
|||||
|
Average all-in aluminum price U.S.
|
2,851
|
2,760
|
3,366
|
3
%
|
(18)
%
|
|||||
|
Average LME
transaction price
|
2,419
|
2,250
|
2,708
|
8
%
|
(17)
%
|
|||||
|
Average Rotterdam premium (ECDP)
|
314
|
276
|
469
|
14
%
|
(41)
%
|
|||||
|
Average all-in aluminum price Europe
|
2,733
|
2,526
|
3,177
|
8
%
|
(20)
%
|
|||||
|
For the years ended December 31,
|
||||||||||||
|
(in millions of U.S. dollars and as a % of revenue)
|
2024
|
2023
|
2022
|
|||||||||
|
Revenue
|
7,335
|
100
%
|
7,826
|
100
%
|
8,532
|
100
%
|
||||||
|
Cost of sales (excluding depreciation
and amortization)
|
(6,397)
|
87
%
|
(6,771)
|
87
%
|
(7,569)
|
89
%
|
||||||
|
Depreciation and amortization
|
(304)
|
4
%
|
(300)
|
4
%
|
(290)
|
3
%
|
||||||
|
Selling and administrative expenses
|
(313)
|
4
%
|
(317)
|
4
%
|
(284)
|
3
%
|
||||||
|
Research and development expenses
|
(49)
|
1
%
|
(52)
|
1
%
|
(46)
|
1
%
|
||||||
|
Other gains and losses - net
|
(26)
|
—
%
|
(43)
|
1
%
|
(90)
|
1
%
|
||||||
|
Finance costs - net
|
(111)
|
2
%
|
(111)
|
1
%
|
(103)
|
1
%
|
||||||
|
Income before tax
|
135
|
2
%
|
232
|
3
%
|
150
|
2
%
|
||||||
|
Income tax (expense) / benefit
|
(75)
|
1
%
|
(75)
|
1
%
|
165
|
2
%
|
||||||
|
Net income
|
60
|
1
%
|
157
|
2
%
|
315
|
4
%
|
||||||
|
Shipment volumes (in kt)
|
1,438
|
n/a
|
1,492
|
n/a
|
1,580
|
n/a
|
||||||
|
(in millions of U.S. dollar)
|
Total
|
|
|
Revenue for the year ended December 31, 2023
|
7,826
|
|
|
Volume
|
(382)
|
|
|
Price and product mix
|
(152)
|
|
|
Metal price
|
132
|
|
|
Foreign exchange and other
|
(89)
|
|
|
Revenue for the year ended December 31, 2024
|
7,335
|
|
Year ended December 31,
|
||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
||
|
Operating income and expenses
|
||||
|
Realized gains / (losses) on derivatives
|
12
|
(50)
|
||
|
Unrealized losses on derivatives at fair value through profit and loss - net
|
(1)
|
(3)
|
||
|
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and
liabilities – net
|
1
|
(2)
|
||
|
Impairment of assets
|
(24)
|
(22)
|
||
|
Restructuring costs
|
(11)
|
—
|
||
|
(Losses) / gains on disposal
|
(4)
|
41
|
||
|
Result from the flood in Valais
|
2
|
—
|
||
|
Non-operating income and expenses
|
||||
|
Expenses on factoring arrangements
|
(22)
|
(24)
|
||
|
Pension and other post-employment benefits
|
11
|
14
|
||
|
Other
|
10
|
3
|
||
|
Total other gains and losses - net
|
(26)
|
(43)
|
||
|
For years ended December 31,
|
||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
||
|
Realized (losses) / gains on foreign currency derivatives - net
|
(10)
|
18
|
||
|
Realized gains / (losses) on commodities derivatives - net
|
22
|
(68)
|
||
|
Realized gains / (losses) on derivatives
|
12
|
(50)
|
||
|
Unrealized (losses) / gains on foreign currency derivatives - net
|
(20)
|
(14)
|
||
|
Unrealized gains on commodities derivatives - net
|
19
|
11
|
||
|
Unrealized losses on derivatives at fair value through profit and loss - net
|
(1)
|
(3)
|
||
|
(in millions of U.S. dollar)
|
Total
|
|
|
Revenue for the year ended December 31, 2022
|
8,532
|
|
|
Volume
|
(398)
|
|
|
Price and product mix
|
647
|
|
|
Metal price
|
(1,188)
|
|
|
Foreign exchange and other
|
232
|
|
|
Revenue for the year ended December 31, 2023
|
7,826
|
|
Year ended December 31,
|
||||
|
(in millions of U.S. dollar)
|
2023
|
2022
|
||
|
Operating income and expenses
|
||||
|
Realized losses on derivatives
|
(50)
|
(8)
|
||
|
Unrealized losses on derivatives at fair value through profit and loss - net
|
(3)
|
(48)
|
||
|
Unrealized exchange losses from the remeasurement of monetary assets and liabilities –
net
|
(2)
|
(2)
|
||
|
Impairment of assets
|
(22)
|
(16)
|
||
|
Restructuring costs
|
—
|
(1)
|
||
|
Gains / (losses) on disposal
|
41
|
(5)
|
||
|
Non-operating income and expenses
|
||||
|
Expenses on factoring arrangements
|
(24)
|
(16)
|
||
|
Pension and other post-employment benefits
|
14
|
2
|
||
|
Other
|
3
|
4
|
||
|
Total other gains and losses - net
|
(43)
|
(90)
|
||
|
For years ended December 31,
|
||||
|
(in millions of U.S. dollar)
|
2023
|
2022
|
||
|
Realized gains / (losses) on foreign currency derivatives - net
|
18
|
(1)
|
||
|
Realized losses on commodities derivatives - net
|
(68)
|
(7)
|
||
|
Realized losses on derivatives
|
(50)
|
(8)
|
||
|
Unrealized (losses) / gains on foreign currency derivatives - net
|
(14)
|
8
|
||
|
Unrealized gains / (losses) on commodities derivatives - net
|
11
|
(56)
|
||
|
Unrealized losses on derivatives at fair value through profit and loss - net
|
(3)
|
(48)
|
||
|
For years ended December 31,
|
||||||||||||
|
(in millions of U.S. dollars
and as a % of revenue)
|
2024
|
2023
|
2022
|
|||||||||
|
A&T
|
1,816
|
25
%
|
1,868
|
24
%
|
1,786
|
21
%
|
||||||
|
P&ARP
|
4,196
|
57
%
|
4,214
|
54
%
|
4,900
|
57
%
|
||||||
|
AS&I
|
1,432
|
20
%
|
1,762
|
23
%
|
1,955
|
23
%
|
||||||
|
Holdings and Corporate
|
6
|
—
%
|
21
|
—
%
|
—
|
—
%
|
||||||
|
Inter-segment eliminations
|
(115)
|
n.m
|
(39)
|
n.m
|
(110)
|
n.m
|
||||||
|
Total revenue
|
7,335
|
100
%
|
7,826
|
100
%
|
8,532
|
100
%
|
||||||
|
For years ended December 31,
|
|||||||||||
|
(in kt
as a % of shipments)
|
2024
|
2023
|
2022
|
||||||||
|
A&T
|
209
|
15
%
|
219
|
15
%
|
222
|
14
%
|
|||||
|
P&ARP
|
1,027
|
71
%
|
1,030
|
69
%
|
1,089
|
69
%
|
|||||
|
AS&I
|
201
|
14
%
|
243
|
16
%
|
268
|
17
%
|
|||||
|
Holdings and Corporate
|
—
|
—
%
|
—
|
—
%
|
—
|
—
%
|
|||||
|
Total shipments
|
1,438
|
100
%
|
1,492
|
100
%
|
1,580
|
100
%
|
|||||
|
For years ended December 31,
|
||||||||||||
|
(in millions of U.S. dollar and as a % of revenue)
|
2024
|
2023
|
2022
|
|||||||||
|
A&T
|
285
|
16
%
|
351
|
19
%
|
228
|
13
%
|
||||||
|
P&ARP
|
242
|
6
%
|
305
|
7
%
|
328
|
7
%
|
||||||
|
AS&I
|
74
|
5
%
|
129
|
7
%
|
143
|
7
%
|
||||||
|
Holdings and Corporate
|
(33)
|
n.m
|
(31)
|
n.m
|
(21)
|
n.m
|
||||||
|
For years ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
A&T
|
285
|
351
|
228
|
|||
|
P&ARP
|
242
|
305
|
328
|
|||
|
AS&I
|
74
|
129
|
143
|
|||
|
H&C
|
(33)
|
(31)
|
(21)
|
|||
|
Segment Adjusted EBITDA
|
568
|
754
|
678
|
|||
|
Metal price lag (A)
|
55
|
(92)
|
(31)
|
|||
|
Depreciation and amortization
|
(304)
|
(300)
|
(290)
|
|||
|
Impairment of assets (B)
|
(24)
|
(22)
|
(16)
|
|||
|
Share based compensation costs
|
(25)
|
(22)
|
(18)
|
|||
|
Pension and other post-employment benefits - non operating gains
|
11
|
14
|
2
|
|||
|
Restructuring costs (C)
|
(11)
|
—
|
(1)
|
|||
|
Unrealized losses on derivatives
|
(1)
|
(3)
|
(48)
|
|||
|
Unrealized exchange gains / (losses) from the remeasurement of monetary
assets and liabilities – net
|
1
|
(2)
|
(2)
|
|||
|
(Losses) / gains on disposal (D)
|
(4)
|
41
|
(5)
|
|||
|
Other (E)
|
2
|
(1)
|
—
|
|||
|
Expenses on factoring arrangements
|
(22)
|
(24)
|
(16)
|
|||
|
Finance costs - net
|
(111)
|
(111)
|
(103)
|
|||
|
Income before tax
|
135
|
232
|
150
|
|||
|
Income tax (expense) / benefit
|
(75)
|
(75)
|
165
|
|||
|
Net income
|
60
|
157
|
315
|
|||
|
(in millions of U.S. dollar)
|
A&T
|
P&ARP
|
AS&I
|
|||
|
Segment Adjusted EBITDA for the year ended December 31, 2022
|
228
|
328
|
143
|
|||
|
Volume
|
(9)
|
(40)
|
(28)
|
|||
|
Price and product mix
|
243
|
168
|
66
|
|||
|
Costs
|
(118)
|
(152)
|
(53)
|
|||
|
Foreign exchange and other
|
7
|
1
|
1
|
|||
|
Segment Adjusted EBITDA for the year ended December 31, 2023
|
351
|
305
|
129
|
|||
|
Volume
|
(19)
|
—
|
(22)
|
|||
|
Price and product mix
|
(48)
|
(18)
|
(25)
|
|||
|
Costs
|
11
|
(46)
|
20
|
|||
|
Flood impact
|
(13)
|
—
|
(20)
|
|||
|
Foreign exchange and other
|
3
|
1
|
(8)
|
|||
|
Segment Adjusted EBITDA for the year ended December 31, 2024
|
285
|
242
|
74
|
|
For years ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Net Cash Flows from / (used in)
|
||||||
|
Operating activities
|
301
|
432
|
365
|
|||
|
Investing activities
|
(313)
|
(216)
|
(196)
|
|||
|
Financing activities
|
(61)
|
(177)
|
(150)
|
|||
|
Net (decrease) / increase in cash and cash equivalents, excluding the
effect of exchange rate changes
|
(73)
|
39
|
19
|
|||
|
For years ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Net income
|
60
|
157
|
315
|
|||
|
Income tax expense
|
75
|
75
|
(165)
|
|||
|
Finance costs - net
|
111
|
111
|
103
|
|||
|
Expenses on factoring arrangements
|
22
|
24
|
16
|
|||
|
Depreciation and amortization
|
304
|
300
|
290
|
|||
|
Impairment of assets (B)
|
24
|
22
|
16
|
|||
|
Restructuring costs (C)
|
11
|
—
|
1
|
|||
|
Unrealized losses / (gains) on derivatives
|
1
|
3
|
48
|
|||
|
Unrealized exchange losses / (gains) from the remeasurement of
monetary assets and liabilities – net
|
(1)
|
2
|
2
|
|||
|
Pension and other post-employment benefits - non operating gains
|
(11)
|
(14)
|
(2)
|
|||
|
Share based compensation costs
|
25
|
22
|
18
|
|||
|
Losses / (gains) on disposal (D)
|
4
|
(41)
|
5
|
|||
|
Other (E)
|
(2)
|
1
|
—
|
|||
|
Adjusted EBITDA
1
|
623
|
662
|
647
|
|||
|
of which Metal price lag
(A)
|
55
|
(92)
|
(31)
|
|||
|
(in millions of U.S. dollar)
|
Effect on income
before tax
|
Effect on pretax
equity
|
||
|
Trade receivables
|
3
|
—
|
||
|
Trade payables
|
(32)
|
—
|
||
|
Derivatives on commercial transactions (A)
|
(36)
|
(42)
|
||
|
Net commercial transaction exposure
|
(65)
|
(42)
|
||
|
Cash in Bank and intercompany loans
|
109
|
—
|
||
|
Borrowings
|
(131)
|
—
|
||
|
Derivatives on financing transactions
|
22
|
—
|
||
|
Net financing transaction exposure
|
—
|
—
|
||
|
Total
|
(65)
|
(42)
|
|
(in millions of U.S. dollar)
|
Effect on net
income
|
Effect on equity
|
||
|
10% strengthening U.S. dollar versus euro
|
(7)
|
(58)
|
|
Year ended December 31,
|
||||||||
|
(in millions of U.S. dollar)
|
Notes
|
2024
|
2023
|
2022
|
||||
|
Revenue
|
2
|
|
|
|
||||
|
Cost of sales (excluding depreciation and amortization)
|
(
|
(
|
(
|
|||||
|
Depreciation and amortization
|
(
|
(
|
(
|
|||||
|
Selling and administrative expenses
|
(
|
(
|
(
|
|||||
|
Research and development expenses
|
(
|
(
|
(
|
|||||
|
Other gains and losses - net
|
5
|
(
|
(
|
(
|
||||
|
Finance costs - net
|
6
|
(
|
(
|
(
|
||||
|
Income before tax
|
|
|
|
|||||
|
Income tax (expense) / benefit
|
7
|
(
|
(
|
|
||||
|
Net income
|
|
|
|
|||||
|
Net income attributable to:
|
||||||||
|
Equity holders of Constellium
|
|
|
|
|||||
|
Non-controlling interests
|
|
|
|
|||||
|
Net income
|
|
|
|
|||||
|
Earnings per share attributable to the equity holders of
Constellium (in dollars)
|
Notes
|
2024
|
2023
|
2022
|
||||
|
Basic
|
8
|
|
|
|
||||
|
Diluted
|
8
|
|
|
|
|
Year ended December 31,
|
||||||||
|
(in millions of U.S. dollar)
|
Notes
|
2024
|
2023
|
2022
|
||||
|
Net income
|
|
|
|
|||||
|
Other comprehensive (loss) / income
|
||||||||
|
Net change in post-employment benefit obligations
|
|
(
|
|
|||||
|
Income tax on net change in post-employment benefit
obligations
|
(
|
|
(
|
|||||
|
Cash flow hedges
|
16
|
(
|
|
(
|
||||
|
Income tax on cash flow hedges
|
|
(
|
|
|||||
|
Currency translation differences
|
(
|
(
|
|
|||||
|
Other comprehensive (loss) / income
|
(
|
(
|
|
|||||
|
Total comprehensive income
|
|
|
|
|||||
|
Attributable to :
|
||||||||
|
Equity holders of Constellium
|
|
|
|
|||||
|
Non-controlling interests
|
|
|
|
|||||
|
Total comprehensive income
|
|
|
|
|||||
|
At December 31,
|
||||||
|
(in millions of U.S. dollar) except share data
|
Notes
|
2024
|
2023
|
|||
|
Assets
|
||||||
|
Current assets
|
||||||
|
Cash and cash equivalents
|
|
|
||||
|
Trade receivables and other, net
|
9
|
|
|
|||
|
Inventories
|
10
|
|
|
|||
|
Fair value of derivatives instruments and other financial assets
|
16
|
|
|
|||
|
Total current assets
|
|
|
||||
|
Non-current assets
|
||||||
|
Property, plant and equipment, net
|
11
|
|
|
|||
|
Goodwill
|
13
|
|
|
|||
|
Intangible assets, net
|
13
|
|
|
|||
|
Deferred tax assets
|
7
|
|
|
|||
|
Trade receivables and other, net
|
9
|
|
|
|||
|
Fair value of derivatives instruments
|
16
|
|
|
|||
|
Total non-current assets
|
|
|
||||
|
Total assets
|
|
|
||||
|
Liabilities
|
||||||
|
Current liabilities
|
||||||
|
Trade payables and other
|
14
|
|
|
|||
|
Short-term debt
|
15
|
|
|
|||
|
Fair value of derivatives instruments
|
16
|
|
|
|||
|
Income tax payable
|
|
|
||||
|
Pension and other benefit obligations
|
17
|
|
|
|||
|
Provisions
|
18
|
|
|
|||
|
Total current liabilities
|
|
|
||||
|
Non-current liabilities
|
||||||
|
Trade payables and other
|
14
|
|
|
|||
|
Long-term debt
|
15
|
|
|
|||
|
Fair value of derivatives instruments
|
16
|
|
|
|||
|
Pension and other benefit obligations
|
17
|
|
|
|||
|
Provisions
|
18
|
|
|
|||
|
Deferred tax liabilities
|
7
|
|
|
|||
|
Total non-current liabilities
|
|
|
||||
|
Total liabilities
|
|
|
||||
|
Commitments and contingencies
|
21
|
|
|
|||
|
Shareholder's equity
|
||||||
|
Ordinary shares, par value
€
2024
and
2023
|
19
|
|
|
|||
|
Additional paid in capital
|
19
|
|
|
|||
|
Accumulated other comprehensive income
|
20
|
(
|
|
|||
|
Retained earnings and other reserves
|
|
|
||||
|
Equity attributable to equity holders of Constellium
|
|
|
||||
|
Non-controlling interests
|
|
|
||||
|
Total equity
|
|
|
||||
|
Total equity and liabilities
|
|
|
||||
|
(in millions of U.S. dollar)
|
Ordinary
shares
|
Additional
paid in
capital
|
Treasury
shares
|
Accumulated
other
comprehensive
(loss) / income
|
Other
reserves
|
Retained
earnings
|
Total
|
Non-
controlling
interests
|
Total
equity
|
|||||||||
|
At January 1, 2024
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Net income
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|
|||||||||
|
Other comprehensive income /
(loss)
|
—
|
—
|
—
|
(
|
—
|
—
|
(
|
(
|
(
|
|||||||||
|
Total comprehensive income /
(loss)
|
—
|
—
|
—
|
(
|
—
|
|
|
|
|
|||||||||
|
Share-based compensation
|
—
|
—
|
—
|
—
|
|
—
|
|
—
|
|
|||||||||
|
Repurchase of ordinary shares
|
—
|
—
|
(
|
—
|
—
|
—
|
(
|
—
|
(
|
|||||||||
|
Allocation of treasury shares to
share-based compensation plan
vested
|
—
|
—
|
|
—
|
—
|
(
|
|
—
|
|
|||||||||
|
Transactions with non-
controlling interests
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
|||||||||
|
At December 31, 2024
|
|
|
(
|
(
|
|
|
|
|
|
|
(in millions of U.S. dollar)
|
Ordinary
shares
|
Additional
paid in
capital
|
Treasury
shares
|
Accumulated
other
comprehensive
income / (loss)
|
Other
reserves
|
Retained
earnings
|
Total
|
Non-
controlling
interests
|
Total
equity
|
|||||||||
|
At January 1, 2023
|
|
|
|
|
|
(
|
|
|
|
|||||||||
|
Net income
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|
|||||||||
|
Other comprehensive income /
(loss)
|
—
|
—
|
—
|
(
|
—
|
—
|
(
|
—
|
(
|
|||||||||
|
Total comprehensive income /
(loss)
|
—
|
—
|
—
|
(
|
—
|
|
|
|
|
|||||||||
|
Share-based compensation
|
—
|
—
|
—
|
—
|
|
—
|
|
—
|
|
|||||||||
|
Transactions with non-controlling
interests
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
|||||||||
|
At December 31, 2023
|
|
|
|
|
|
|
|
|
|
|
(in millions of U.S. dollar)
|
Ordinary
shares
|
Additional
paid in
capital
|
Treasury
shares
|
Accumulated
other
comprehensive
(loss) / income
|
Other
reserves
|
Retained
earnings
|
Total
|
Non-
controlling
interests
|
Total
equity
|
|||||||||
|
At January 1, 2022
|
|
|
|
(
|
|
(
|
|
|
|
|||||||||
|
Net income
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|
|||||||||
|
Other comprehensive income /
(loss)
|
—
|
—
|
—
|
|
—
|
—
|
|
(
|
|
|||||||||
|
Total comprehensive income /
(loss)
|
—
|
—
|
—
|
|
—
|
|
|
|
|
|||||||||
|
Share-based compensation
|
—
|
—
|
—
|
—
|
|
—
|
|
—
|
|
|||||||||
|
Transactions with non-controlling
interests
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
|||||||||
|
At December 31, 2022
|
|
|
|
|
|
(
|
|
|
|
|||||||||
|
Year ended December 31,
|
||||||||
|
(in millions of U.S. dollar)
|
Notes
|
2024
|
2023
|
2022
|
||||
|
Net income
|
|
|
|
|||||
|
Adjustments
|
||||||||
|
Depreciation and amortization
|
11, 13
|
|
|
|
||||
|
Impairment of assets
|
5
|
|
|
|
||||
|
Pension and other long-term benefits
|
17
|
|
|
|
||||
|
Finance costs - net
|
6
|
|
|
|
||||
|
Income tax expense / (benefit)
|
7
|
|
|
(
|
||||
|
Unrealized losses on derivatives - net and from
remeasurement of monetary assets and liabilities - net
|
|
|
|
|||||
|
Losses / (gains) on disposal
|
5
|
|
(
|
|
||||
|
Other - net
|
|
|
|
|||||
|
Changes in working capital
|
||||||||
|
Inventories
|
(
|
|
(
|
|||||
|
Trade receivables
|
(
|
(
|
|
|||||
|
Trade payables
|
(
|
(
|
|
|||||
|
Other
|
(
|
(
|
(
|
|||||
|
Change in provisions
|
|
(
|
(
|
|||||
|
Pension and other long-term benefits paid
|
17
|
(
|
(
|
(
|
||||
|
Interest paid
|
(
|
(
|
(
|
|||||
|
Income tax paid
|
(
|
(
|
(
|
|||||
|
Net cash flows from operating activities
|
|
|
|
|||||
|
Purchases of property, plant and equipment
|
3
|
(
|
(
|
(
|
||||
|
Property, plant and equipment inflows
|
3
|
|
|
|
||||
|
Collection of deferred purchase price receivable
|
9
|
|
|
|
||||
|
Acquisition of subsidiaries net of cash acquired
|
23
|
|
|
|
||||
|
Proceeds from disposals, net of cash
|
23
|
|
|
|
||||
|
Other investing activities
|
|
|
(
|
|||||
|
Net cash flows used in investing activities
|
(
|
(
|
(
|
|||||
|
Repurchase of ordinary shares
|
(
|
|
|
|||||
|
Proceeds from issuance of long-term debt
|
|
|
|
|||||
|
Repayments of long-term debt
|
(
|
(
|
(
|
|||||
|
Net change in revolving credit facilities and short-term debt
|
|
(
|
|
|||||
|
Finance lease repayments
|
(
|
(
|
(
|
|||||
|
Payment of financing costs and redemption fees
|
(
|
|
(
|
|||||
|
Transactions with non-controlling interests
|
(
|
(
|
(
|
|||||
|
Other financing activities
|
|
(
|
(
|
|||||
|
Net cash flows used in financing activities
|
(
|
(
|
(
|
|||||
|
Net (decrease) / increase in cash and cash equivalents
|
(
|
|
|
|||||
|
Cash and cash equivalents - beginning of year
|
|
|
|
|||||
|
Transfer of cash and cash equivalents from / (to) assets
classified as held for sale
|
|
|
(
|
|||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(
|
|
(
|
|||||
|
Cash and cash equivalents - end of year
|
|
|
|
|||||
|
Year ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Aerospace rolled products
|
|
|
|
|||
|
Transportation, industry, defense and other rolled products
|
|
|
|
|||
|
Packaging rolled products
|
|
|
|
|||
|
Automotive rolled products
|
|
|
|
|||
|
Specialty and other thin-rolled products
|
|
|
|
|||
|
Automotive extruded products
|
|
|
|
|||
|
Other extruded products
|
|
|
|
|||
|
Other
|
|
|
|
|||
|
Total revenue by product line
|
|
|
|
|||
|
Year ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
United States
|
|
|
|
|||
|
Germany
|
|
|
|
|||
|
France
|
|
|
|
|||
|
Spain
|
|
|
|
|||
|
United Kingdom
|
|
|
|
|||
|
Poland
|
|
|
|
|||
|
Czech Republic
|
|
|
|
|||
|
All other
|
|
|
|
|||
|
Total revenue by destination of shipment
|
|
|
|
|||
|
2024
|
2023
|
2022
|
|||||||||||||
|
(in millions of U.S. dollar)
|
A&T
|
P&ARP
|
AS&I
|
H&C
|
A&T
|
P&ARP
|
AS&I
|
H&C
|
A&T
|
P&ARP
|
AS&I
|
H&C
|
|||
|
Segment revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Inter-segment elimination
|
(
|
(
|
(
|
|
(
|
(
|
(
|
|
(
|
(
|
(
|
|
|||
|
External revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Cost of metal
|
(
|
(
|
(
|
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
|
|||
|
Production costs
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
|||
|
Other segment expenses (A)
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
|||
|
Segment adjusted
EBITDA
|
|
|
|
(
|
|
|
|
(
|
|
|
|
(
|
|||
|
Year ended December 31,
|
||||||||
|
(in millions of U.S. dollar)
|
Notes
|
2024
|
2023
|
2022
|
||||
|
A&T
|
|
|
|
|||||
|
P&ARP
|
|
|
|
|||||
|
AS&I
|
|
|
|
|||||
|
H&C
|
(
|
(
|
(
|
|||||
|
Segment Adjusted EBITDA
|
|
|
|
|||||
|
Metal price lag (A)
|
|
(
|
(
|
|||||
|
Depreciation and amortization
|
11, 13
|
(
|
(
|
(
|
||||
|
Impairment of assets (B)
|
5
|
(
|
(
|
(
|
||||
|
Share based compensation costs
|
22
|
(
|
(
|
(
|
||||
|
Pension and other post-employment benefits - non operating
gains
|
5, 17
|
|
|
|
||||
|
Restructuring costs (C)
|
5
|
(
|
|
(
|
||||
|
Unrealized losses on derivatives
|
5
|
(
|
(
|
(
|
||||
|
Unrealized exchange gains / (losses) from the remeasurement of
monetary assets and liabilities – net
|
5
|
|
(
|
(
|
||||
|
(Losses) / gains on disposal (D)
|
5
|
(
|
|
(
|
||||
|
Other (E)
|
|
(
|
|
|||||
|
Expenses on factoring arrangements
|
9
|
(
|
(
|
(
|
||||
|
Finance costs - net
|
6
|
(
|
(
|
(
|
||||
|
Income before tax
|
|
|
|
|||||
|
Income tax (expense) / benefit
|
7
|
(
|
(
|
|
||||
|
Net income
|
|
|
|
|||||
|
Year ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
A&T
|
(
|
(
|
(
|
|||
|
P&ARP
|
(
|
(
|
(
|
|||
|
AS&I
|
(
|
(
|
(
|
|||
|
H&C
|
(
|
(
|
(
|
|||
|
Total capital expenditures (A)
|
(
|
(
|
(
|
|||
|
Year ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
A&T
|
(
|
(
|
(
|
|||
|
P&ARP
|
(
|
(
|
(
|
|||
|
AS&I
|
(
|
(
|
(
|
|||
|
H&C
|
(
|
(
|
(
|
|||
|
Total depreciation, amortization and impairment expense
|
(
|
(
|
(
|
|||
|
At December 31,
|
||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
||
|
A&T
|
|
|
||
|
P&ARP
|
|
|
||
|
AS&I
|
|
|
||
|
H&C
|
|
|
||
|
Segment assets
|
|
|
||
|
Deferred income tax assets
|
|
|
||
|
Cash and cash equivalents
|
|
|
||
|
Fair value of derivatives instruments and other financial assets
|
|
|
||
|
Total assets
|
|
|
||
|
At December 31,
|
||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
||
|
United States
|
|
|
||
|
France
|
|
|
||
|
Germany
|
|
|
||
|
Czech Republic
|
|
|
||
|
Other
|
|
|
||
|
Total property plant and equipment
|
|
|
||
|
Year ended December 31,
|
||||||||
|
(in millions of U.S. dollar)
|
Notes
|
2024
|
2023
|
2022
|
||||
|
Operating income and expenses
|
||||||||
|
Realized gains / (losses) on derivatives (A)
|
|
(
|
(
|
|||||
|
Unrealized losses on derivatives at fair value through profit and
loss - net (A)
|
(
|
(
|
(
|
|||||
|
Unrealized exchange gains / (losses) from the remeasurement of
monetary assets and liabilities – net
|
|
(
|
(
|
|||||
|
Impairment of assets (B)
|
(
|
(
|
(
|
|||||
|
Restructuring costs (C)
|
(
|
|
(
|
|||||
|
(Losses) / gains on disposal (D)
|
(
|
|
(
|
|||||
|
Result from the flood in Valais (E)
|
|
|
|
|||||
|
Non-operating income and expenses
|
||||||||
|
Expenses on factoring arrangements
|
9
|
(
|
(
|
(
|
||||
|
Pension and other post-employment benefits
|
17
|
|
|
|
||||
|
Other (F)
|
|
|
|
|||||
|
Total other gains and losses - net
|
(
|
(
|
(
|
|||||
|
Year ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Interest expense on borrowings (A)
|
(
|
(
|
(
|
|||
|
Interest expense on finance leases
|
(
|
(
|
(
|
|||
|
Interest cost on pension and other long-term benefits
|
(
|
(
|
(
|
|||
|
Net loss on settlement of debt (B)
|
(
|
|
|
|||
|
Realized and unrealized gains on debt derivatives at fair value (C)
|
|
|
|
|||
|
Realized and unrealized exchange (losses) / gains on financing activities -
net (C)
|
(
|
(
|
|
|||
|
Other finance expenses
|
(
|
(
|
(
|
|||
|
Capitalized borrowing costs (D)
|
|
|
|
|||
|
Finance expenses
|
(
|
(
|
(
|
|||
|
Finance costs - net
|
(
|
(
|
(
|
|||
|
Year ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Domestic (France)
|
|
|
|
|||
|
Foreign
|
(
|
|
|
|||
|
Income before tax
|
|
|
|
|||
|
Year ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Income before tax
|
|
|
|
|||
|
Statutory tax rate applicable to the parent company
|
|
|
|
|||
|
Income tax expense calculated at statutory tax rate
|
(
|
(
|
(
|
|||
|
Effect of foreign tax rate (A)
|
(
|
|
|
|||
|
Investment in subsidiaries (B)
|
(
|
|
(
|
|||
|
Changes in valuation allowance (C)
|
(
|
(
|
|
|||
|
Change in tax laws and rates (D)
|
|
(
|
|
|||
|
Prior year adjustments
|
(
|
(
|
|
|||
|
BEAT Tax
|
(
|
(
|
(
|
|||
|
Other
|
(
|
(
|
(
|
|||
|
Income tax (expense) / benefit
|
(
|
(
|
|
|||
|
Effective income tax rate
|
|
|
(
|
|||
|
Year ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Domestic (France)
|
(
|
(
|
(
|
|||
|
Foreign
|
(
|
(
|
(
|
|||
|
Current tax expense
|
(
|
(
|
(
|
|||
|
Domestic (France)
|
(
|
|
(
|
|||
|
Foreign
|
(
|
(
|
|
|||
|
Deferred tax (expense) / benefit
|
(
|
(
|
|
|||
|
Income tax (expense) / benefit
|
(
|
(
|
|
|||
|
Year ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Unrecognized tax benefits at January 1, (A)
|
|
|
|
|||
|
Additions for tax position of the current year
|
|
|
|
|||
|
Additions for tax position of prior years
|
|
|
|
|||
|
Reductions for tax positions of prior years (B)
|
(
|
|
|
|||
|
Settlements with tax authorities
|
(
|
(
|
|
|||
|
Reductions for expiration of statute of limitations
|
|
(
|
(
|
|||
|
Unrecognized tax benefits at December 31, (A)
|
|
|
|
|||
|
At December 31,
|
||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
||
|
Net deferred income tax assets
|
|
|
||
|
Net deferred income tax liabilities
|
(
|
(
|
||
|
Net deferred taxes
|
|
|
||
|
At December 31,
|
||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
||
|
Deferred income tax assets
|
||||
|
Tax losses carried forward
|
|
|
||
|
Long term assets
|
|
|
||
|
Pensions
|
|
|
||
|
Derivative valuation
|
|
|
||
|
Interest carried forward
|
|
|
||
|
Other (A)
|
|
|
||
|
Total deferred income tax assets
|
|
|
||
|
Less: valuation allowance (B)
|
(
|
(
|
||
|
Deferred income tax assets, net of valuation allowance
|
|
|
||
|
Deferred income tax liabilities
|
||||
|
Long-term assets
|
(
|
(
|
||
|
Inventories
|
(
|
(
|
||
|
Other
|
|
|
||
|
Deferred income tax liabilities
|
(
|
(
|
||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
At January 1,
|
|
|
|
|||
|
Deduction
|
(
|
(
|
(
|
|||
|
Addition
|
|
|
|
|||
|
At December 31,
|
|
|
|
|||
|
At December 31, 2024
|
||||||||
|
(in millions of U.S. dollar)
|
Tax Losses
Carried Forward
|
Valuation
Allowance
|
Carryforward
Period
|
Earliest Year of
Expiration
|
||||
|
Net operating loss
|
||||||||
|
United States
|
|
|
Indefinite
|
—
|
||||
|
United States
|
|
|
20 years
|
2032
|
||||
|
France
|
|
(
|
Indefinite
|
—
|
||||
|
Germany
|
|
(
|
Indefinite
|
—
|
||||
|
Switzerland
|
|
(
|
7 years
|
2028
|
||||
|
China
|
|
(
|
5 years
|
2025
|
||||
|
Other
|
|
(
|
> 5 years or
indefinite
|
2027
|
||||
|
Total
|
|
(
|
||||||
|
Year ended December 31,
|
||||||
|
(in millions of US Dollars except share and per share amounts )
|
2024
|
2023
|
2022
|
|||
|
Numerator:
|
||||||
|
Net income attributable to equity holders of Constellium
|
|
|
|
|||
|
Denominator:
|
||||||
|
Basic - weighted-average ordinary shares outstanding
|
|
|
|
|||
|
Dilutive effect of non-vested restricted stock units and performance-
based restricted stock units
|
|
|
|
|||
|
Diluted - weighted-average ordinary shares, of restricted stock units and
performance-based restricted stock units
|
|
|
|
|||
|
Basic earnings per share
|
$
|
$
|
$
|
|||
|
Diluted earnings per share
|
$
|
$
|
$
|
|||
|
At December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(in millions of U.S. dollar)
|
Non-current
|
Current
|
Non-current
|
Current
|
||||
|
Trade receivables - gross
|
|
|
|
|
||||
|
Allowance for doubtful receivables
|
|
(
|
|
(
|
||||
|
Total trade receivables - net
|
|
|
|
|
||||
|
Income tax receivables
|
|
|
|
|
||||
|
Other tax receivables
|
|
|
|
|
||||
|
Contract assets
|
|
|
|
|
||||
|
Other
|
|
|
|
|
||||
|
Total other receivables
|
|
|
|
|
||||
|
Total trade receivables and other
|
|
|
|
|
||||
|
At December 31,
|
||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
||
|
Finished goods
|
|
|
||
|
Work in progress
|
|
|
||
|
Raw materials
|
|
|
||
|
Stores and supplies
|
|
|
||
|
Total inventories
|
|
|
||
|
(in millions of U.S. dollar)
|
Land and
Property
Rights
|
Buildings
|
Machinery
and
Equipment
|
Construction
Work in
Progress
|
Other
|
Property,
Plant and
Equipment
|
||||||
|
At December 31, 2024
|
||||||||||||
|
Gross carrying value
|
|
|
|
|
|
|
||||||
|
Less accumulated depreciation
|
(
|
(
|
(
|
|
(
|
(
|
||||||
|
Net balance at December 31, 2024
|
|
|
|
|
|
|
||||||
|
At December 31, 2023
|
||||||||||||
|
Gross carrying value
|
|
|
|
|
|
|
||||||
|
Less accumulated depreciation
|
(
|
(
|
(
|
|
(
|
(
|
||||||
|
Net balance at December 31, 2023
|
|
|
|
|
|
|
|
At December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Depreciation expense related to property, plant and equipment
|
(
|
(
|
(
|
|||
|
At December 31,
|
||||||
|
(in millions of U.S. dollar)
|
Consolidated Balance Sheets
|
2024
|
2023
|
|||
|
Assets
|
||||||
|
Operating lease right-of-use assets
|
Property, plant and equipment
|
|
|
|||
|
Finance lease assets (A)
|
Property, plant and equipment
|
|
|
|||
|
Total lease assets
|
|
|
||||
|
Liabilities
|
||||||
|
Current:
|
||||||
|
Operating lease liabilities
|
Trade payables and other
|
|
|
|||
|
Finance lease liabilities
|
Short-term debt
|
|
|
|||
|
Non-current:
|
||||||
|
Operating lease liabilities
|
Trade payables and other
|
|
|
|||
|
Finance lease liabilities
|
Long-term debt
|
|
|
|||
|
Total lease liabilities
|
|
|
||||
|
At December 31,
|
||||||||
|
(in millions of U.S. dollar)
|
Consolidated Income Statement
|
2024
|
2023
|
2022
|
||||
|
Operating lease costs (B)
|
Cost of sales (excluding depreciation
and amortization)
|
(
|
(
|
(
|
||||
|
Selling and administrative expenses
|
(
|
(
|
(
|
|||||
|
Depreciation related to finance lease
|
Depreciation and amortization
|
(
|
(
|
(
|
||||
|
At December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Financing cash flows from finance leases
|
(
|
(
|
(
|
|||
|
Operating cash flows from operating leases
|
(
|
(
|
(
|
|||
|
At December 31,
|
||||
|
2024
|
2023
|
|||
|
Weighted-average remaining lease term
|
||||
|
Operating leases
|
|
|
||
|
Finance leases
|
|
|
||
|
Weighted-average discount rate
|
||||
|
Operating leases
|
|
|
||
|
Finance leases
|
|
|
||
|
At December 31, 2024
|
||||
|
(in millions of U.S. dollar)
|
Operating Leases
|
Finance Leases
|
||
|
Years ending
|
||||
|
2025
|
|
|
||
|
2026
|
|
|
||
|
2027
|
|
|
||
|
2028
|
|
|
||
|
2029
|
|
|
||
|
Thereafter
|
|
|
||
|
Total non-cancelable minimum lease payments
|
|
|
||
|
Less: interest
|
(
|
(
|
||
|
Present value of lease liabilities
|
|
|
||
|
(in millions of U.S. dollar)
|
Technology
|
Computer
Software
|
Customer
relationships
|
Work in
Progress
|
Other
|
Total
Intangible
Assets
|
||||||
|
At December 31, 2024
|
||||||||||||
|
Gross carrying value
|
|
|
|
|
|
|
||||||
|
Less accumulated amortization
|
(
|
(
|
(
|
|
(
|
(
|
||||||
|
Net balance at December 31, 2024
|
|
|
|
|
|
|
||||||
|
At December 31, 2023
|
||||||||||||
|
Gross carrying value
|
|
|
|
|
|
|
||||||
|
Less accumulated amortization
|
(
|
(
|
(
|
|
(
|
(
|
||||||
|
Net balance, at December 31, 2023
|
|
|
|
|
|
|
||||||
|
At December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Amortization expense related to intangible assets
|
(
|
(
|
(
|
|||
|
(in millions of US Dollars)
|
At December 31,
2024
|
|
|
Year ending
|
||
|
2025
|
(
|
|
|
2026
|
(
|
|
|
2027
|
(
|
|
|
2028
|
(
|
|
|
2029
|
(
|
|
At December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(in millions of U.S. dollar)
|
Non-current
|
Current
|
Non-current
|
Current
|
||||
|
Trade payables
|
—
|
|
—
|
|
||||
|
Employees' entitlements
|
—
|
|
—
|
|
||||
|
Contract liabilities and other liabilities to customers
|
|
|
|
|
||||
|
Operating lease liabilities
|
|
|
|
|
||||
|
Other payables
|
|
|
|
|
||||
|
Total other
|
|
|
|
|
||||
|
Total trade payables and other
|
|
|
|
|
||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Contract liabilities and other liabilities to customers at January 1,
|
|
|
|
|||
|
Revenue deferred from contract liabilities
|
|
|
|
|||
|
Revenue recognized from contract liabilities
|
(
|
(
|
(
|
|||
|
Effect of changes in foreign currency rates and other changes
|
(
|
(
|
(
|
|||
|
Contract liabilities and other liabilities to customers at December 31,
|
|
|
|
|||
|
At December 31,
|
||||||||||
|
2024
|
2023
|
|||||||||
|
(in millions of U.S. dollar)
|
Nominal
Value in
Currency
|
Nominal
rate
|
Effective
rate
|
Face
Value
|
Debt
issuance
costs
|
Accrued
interest
|
Carrying
value
|
Carrying
value
|
||
|
Secured Pan-U.S. ABL (due 2029) (A)
|
$
|
Floating
|
|
|
|
|
|
|
||
|
Senior Unsecured Notes
|
—
|
—
|
—
|
—
|
||||||
|
Issued November 2017 and due 2026 (B)
|
$
|
|
|
|
|
|
|
|
||
|
Issued November 2017 and due 2026 (B)
|
€
|
|
|
|
|
|
|
|
||
|
Issued June 2020 and due 2028
|
$
|
|
|
|
(
|
|
|
|
||
|
Issued February 2021 and due 2029
|
$
|
|
|
|
(
|
|
|
|
||
|
Issued June 2021 and due 2029
|
€
|
|
|
|
(
|
|
|
|
||
|
Issued August 2024 and due 2032 (C)
|
$
|
|
|
|
(
|
|
|
|
||
|
Issued August 2024 and due 2032 (C)
|
€
|
|
|
|
(
|
|
|
|
||
|
Finance lease liabilities
|
|
|
|
|
|
|||||
|
Other loans (D)
|
|
|
|
|
|
|||||
|
Total debt
|
|
(
|
|
|
|
|||||
|
Of which non-current
|
|
|
||||||||
|
Of which current (E)
|
|
|
||||||||
|
(in millions of U.S. dollar)
|
At December 31,
2024
|
|
|
Year ending
|
||
|
2025
|
|
|
|
2026
|
|
|
|
2027
|
|
|
|
2028
|
|
|
|
2029
|
|
|
|
Thereafter
|
|
|
|
Total undiscounted cash flows
|
|
|
At December 31,
|
||||||||||||
|
2024
|
2023
|
|||||||||||
|
(in millions of U.S. dollar)
|
Non-
current
|
Current
|
Total
|
Non-
current
|
Current
|
Total
|
||||||
|
Derivatives that qualify for hedge accounting
|
||||||||||||
|
Currency commercial derivatives
|
|
|
|
|
|
|
||||||
|
Derivatives that do not qualify for hedge accounting
|
||||||||||||
|
Currency commercial derivatives
|
|
|
|
|
|
|
||||||
|
Currency net debt derivatives
|
|
|
|
|
|
|
||||||
|
Energy derivatives
|
|
|
|
|
|
|
||||||
|
Metal derivatives
|
|
|
|
|
|
|
||||||
|
Fair value of derivatives instruments - assets
|
|
|
|
|
|
|
||||||
|
Derivatives that qualify for hedge accounting
|
||||||||||||
|
Currency commercial derivatives
|
|
|
|
|
|
|
||||||
|
Derivatives that do not qualify for hedge accounting
|
||||||||||||
|
Currency commercial derivatives
|
|
|
|
|
|
|
||||||
|
Energy derivatives
|
|
|
|
|
|
|
||||||
|
Metal derivatives
|
|
|
|
|
|
|
||||||
|
Fair value of derivatives instruments - liabilities
|
|
|
|
|
|
|
||||||
|
At December 31,
|
||||||||||||||||
|
2024
|
2023
|
|||||||||||||||
|
(in millions of U.S. dollar)
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||
|
Fair value of derivatives
instruments - assets
|
|
|
|
|
|
|
|
|
||||||||
|
Fair value of derivatives
instruments - liabilities
|
|
|
|
|
|
|
|
|
||||||||
|
Sold currencies
|
Maturity Year
|
Less than 1 year
|
Over 1 year
|
|||
|
USD
|
2025-2029
|
|
|
|||
|
CHF
|
2025-2027
|
|
|
|||
|
CZK
|
2025
|
|
|
|||
|
Other currencies
|
2025-2026
|
|
|
|
Purchased currencies
|
Maturity Year
|
Less than 1 year
|
Over 1 year
|
|||
|
USD
|
2025-2026
|
|
|
|||
|
CHF
|
2025-2028
|
|
|
|||
|
CZK
|
2025-2026
|
|
|
|||
|
Other currencies
|
2025
|
|
|
|
Year ended December 31,
|
||||||||
|
(in millions of U.S. dollar)
|
Notes
|
2024
|
2023
|
2022
|
||||
|
Derivatives that do not qualify for hedge accounting
|
||||||||
|
Included in Other gains and losses - net
|
||||||||
|
Realized (losses) / gains on foreign currency derivatives - net (A)
|
5
|
(
|
|
(
|
||||
|
Unrealized (losses) / gains on foreign currency derivatives - net (B)
|
5
|
(
|
(
|
|
||||
|
Derivatives that qualify for hedge accounting
|
||||||||
|
Included in Other comprehensive income
|
||||||||
|
Unrealized (losses) / gains on foreign currency derivatives - net
|
(
|
|
(
|
|||||
|
Gains reclassified from cash flow hedge reserve to the Consolidated
Income Statement
|
|
|
|
|||||
|
Included in Revenue (C)
|
||||||||
|
Realized losses on foreign currency derivatives - net (A)
|
5
|
(
|
(
|
(
|
||||
|
Unrealized (losses) / gains on foreign currency derivatives - net
|
5
|
(
|
|
|
||||
|
Year ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Derivatives that do not qualify for hedge accounting
|
||||||
|
Included in Finance costs - net
|
||||||
|
Realized gains on foreign currency derivatives - net (A)
|
|
|
|
|||
|
Unrealized (losses) / gains on foreign currency derivatives - net
|
(
|
|
(
|
|||
|
Total
|
|
|
|
|||
|
(in millions of U.S. dollar)
|
Maturity
|
Less than 1 year
|
Over 1 year
|
|||
|
Metal
|
2025-2027
|
|
|
|||
|
Natural gas
|
2025-2027
|
|
|
|
Year ended December 31,
|
||||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
2022
|
|||
|
Derivatives that do not qualify for hedge accounting
|
||||||
|
Included in Other gains and losses - net
|
||||||
|
Realized gains / (losses) on commodities derivatives - net (A)
|
|
(
|
(
|
|||
|
Unrealized gains / (losses) on commodities derivatives - net
|
|
|
(
|
|||
|
At December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Rate of
increase
in
salaries
|
Discount rate
|
Expected
return
rate (A)
|
Rate of
increase
in
salaries
|
Discount rate
|
Expected
return
rate (A)
|
Rate of
increase
in
salaries
|
Discount rate
|
Expected
return
rate (A)
|
||||
|
Pension
|
|
|
|
|
|
|
|
|
|
|||
|
OPEB
|
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|||
|
At December 31,
|
|||||||
|
2024
|
2023
|
||||||
|
(in millions of U.S. dollar)
|
Pension
Benefits
|
OPEB and
Other
Benefits
|
Total
|
Pension
Benefits
|
OPEB and
Other
Benefits
|
Total
|
|
|
Present value of funded obligation
|
|
|
|
|
|
|
|
|
Fair value of plan assets
|
(
|
|
(
|
(
|
|
(
|
|
|
Deficit of funded plans
|
|
|
|
|
|
|
|
|
Present value of unfunded obligation
|
|
|
|
|
|
|
|
|
Net liability arising from defined benefit obligation
|
|
|
|
|
|
|
|
|
of which non-current
|
|
|
|
|
|
|
|
|
of which current
|
|
|
|
|
|
|
|
|
Year ended December 31,
|
||||||||
|
2024
|
2023
|
2022
|
||||||
|
(in millions of U.S. dollar)
|
Pension
|
OPEB and
Other
Benefits
|
Pension
|
OPEB and
Other
Benefits
|
Pension
|
OPEB and
Other
Benefits
|
||
|
Current service cost
|
(
|
(
|
(
|
(
|
(
|
(
|
||
|
Interest cost
|
(
|
(
|
(
|
(
|
(
|
(
|
||
|
Expected return on plan assets
|
|
|
|
|
|
|
||
|
Immediate recognition of gains arising over the year
|
|
|
|
(
|
|
|
||
|
Amortization of past service (cost) / gain
|
|
|
|
|
|
|
||
|
Amortization of net actuarial (loss) / gain
|
(
|
|
|
|
(
|
(
|
||
|
Curtailment and settlements
|
|
|
|
|
|
|
||
|
Total net pension and other long-term benefit cost
|
(
|
|
(
|
(
|
(
|
(
|
||
|
Year ended December 31, 2024
|
||||||||||
|
Defined benefit obligations
|
Plan assets
|
Net defined
benefit
liability
|
||||||||
|
(in millions of U.S. dollar)
|
Pension
benefits
|
OPEB and
Other
Benefits
|
Total
|
|||||||
|
At January 1, 2024
|
|
|
|
(
|
|
|||||
|
Included in the Consolidated Income Statement
|
||||||||||
|
Current service cost
|
|
|
|
—
|
|
|||||
|
Interest cost / (income)
|
|
|
|
(
|
|
|||||
|
Immediate recognition of gains arising over the year
|
|
|
|
—
|
|
|||||
|
Included in the Statement of Comprehensive Income
|
||||||||||
|
Remeasurements due to:
|
||||||||||
|
—actual return less interest on plan assets
|
—
|
—
|
—
|
(
|
(
|
|||||
|
—changes in financial assumptions
|
(
|
(
|
(
|
—
|
(
|
|||||
|
—changes in demographic assumptions
|
|
|
|
—
|
|
|||||
|
—experience (gains)/ losses
|
|
(
|
|
—
|
|
|||||
|
Effects of changes in foreign exchange rates
|
(
|
(
|
(
|
|
(
|
|||||
|
Included in the Consolidated Statement of Cash Flows
|
||||||||||
|
Benefits paid
|
(
|
(
|
(
|
|
(
|
|||||
|
Settlement
|
(
|
|
(
|
|
|
|||||
|
Contributions by the Group
|
—
|
—
|
—
|
(
|
(
|
|||||
|
Contributions by the plan participants
|
|
|
|
(
|
|
|||||
|
At December 31, 2024
|
|
|
|
(
|
|
|||||
|
Year ended December 31, 2023
|
||||||||||
|
Defined benefit obligations
|
Plan Assets
|
Net defined
benefit
liability
|
||||||||
|
(in millions of U.S. dollar)
|
Pension
benefits
|
OPEB and
Other
Benefits
|
Total
|
|||||||
|
At January 1, 2023
|
|
|
|
(
|
|
|||||
|
Included in the Consolidated Income Statement
|
||||||||||
|
Current service cost
|
|
|
|
—
|
|
|||||
|
Interest cost / (income)
|
|
|
|
(
|
|
|||||
|
Immediate recognition of gains arising over the year
|
|
|
|
—
|
|
|||||
|
Included in the Statement of Comprehensive Income
|
||||||||||
|
Remeasurements due to:
|
||||||||||
|
—actual return less interest on plan assets
|
—
|
—
|
—
|
(
|
(
|
|||||
|
—changes in financial assumptions
|
|
|
|
—
|
|
|||||
|
—changes in demographic assumptions
|
|
|
|
—
|
|
|||||
|
—experience (gains)/ losses
|
|
(
|
(
|
—
|
(
|
|||||
|
Past service cost
|
(
|
|
(
|
—
|
(
|
|||||
|
Effects of changes in foreign exchange rates
|
|
|
|
(
|
|
|||||
|
Included in the Consolidated Statement of Cash Flows
|
||||||||||
|
Benefits paid
|
(
|
(
|
(
|
|
(
|
|||||
|
Contributions by the Group
|
—
|
—
|
—
|
(
|
(
|
|||||
|
Contributions by the plan participants
|
|
|
|
(
|
|
|||||
|
Disposed of through business combination
|
(
|
(
|
(
|
|
(
|
|||||
|
At December 31, 2023
|
|
|
|
(
|
|
|||||
|
At December 31,
|
||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
||
|
Cash & cash equivalents
|
|
|
||
|
Equities
|
|
|
||
|
Fixed income
|
|
|
||
|
Property
|
|
|
||
|
Other
|
|
|
||
|
Total fair value of plan assets
|
|
|
||
|
Estimated benefits payments
|
||||
|
(in millions of U.S. dollar)
|
Pensions
|
OPEB and Other
Benefits
|
||
|
Year ended December 31,
|
||||
|
2025
|
|
|
||
|
2026
|
|
|
||
|
2027
|
|
|
||
|
2028
|
|
|
||
|
2029
|
|
|
||
|
2030 to 2034
|
|
|
||
|
At December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(in millions of U.S. dollar)
|
Current
|
Non current
|
Current
|
Non current
|
||||
|
Close down and environmental remediation costs
|
|
|
|
|
||||
|
Restructuring costs
|
|
|
|
|
||||
|
Legal claims and other costs
|
|
|
|
|
||||
|
Total provisions
|
|
|
|
|
||||
|
At December 31,
|
||||
|
(in millions of U.S. dollar)
|
2024
|
2023
|
||
|
Litigation
|
|
|
||
|
Disease claims (A)
|
|
|
||
|
Total provisions for legal claims and other costs
|
|
|
||
|
(in millions of U.S. dollar)
|
||||||
|
Number of shares
|
Ordinary shares
|
Additional paid in
capital
|
||||
|
At January 1, 2024
|
|
|
|
|||
|
At December 31, 2024 (A)
|
|
|
|
|||
|
(in millions of U.S. dollar)
|
Post-
employment
benefit plans
|
Cash flow
hedges
|
Currency
translation
adjustments
|
Accumulated
other
comprehensive
(loss) / income
|
||||
|
At January 1, 2024
|
|
(
|
(
|
|
||||
|
Other comprehensive income / (loss) before reclassification
|
|
(
|
(
|
(
|
||||
|
Amounts reclassified from accumulated other
comprehensive loss to the income statement
|
(
|
|
|
|
||||
|
At December 31, 2024
|
|
(
|
(
|
(
|
|
(in millions of U.S. dollar)
|
Post-
employment
benefit plans
|
Cash flow
hedges
|
Currency
translation
adjustments
|
Accumulated
other
comprehensive
income / (loss)
|
||||
|
At January 1, 2023
|
|
(
|
(
|
|
||||
|
Other comprehensive income / (loss) before reclassification
|
(
|
(
|
|
(
|
||||
|
Amounts reclassified from accumulated other
comprehensive loss to the income statement
|
(
|
|
|
(
|
||||
|
Amounts from disposal of entities reclassified to the income
statement
|
(
|
|
(
|
(
|
||||
|
At December 31, 2023
|
|
(
|
(
|
|
|
(in millions of U.S. dollar)
|
Post-
employment
benefit plans
|
Cash flow
hedges
|
Currency
translation
adjustments
|
Accumulated
other
comprehensive
income / (loss)
|
||||
|
At January 1, 2022
|
(
|
(
|
(
|
(
|
||||
|
Other comprehensive income / (loss) before reclassification
|
|
(
|
|
|
||||
|
Amounts reclassified from accumulated other
comprehensive loss to the income statement
|
(
|
|
|
|
||||
|
At December 31, 2022
|
|
(
|
(
|
|
|
2024 PSUs
|
2023 PSUs
|
|||
|
Fair value at grant date (in dollars)
|
|
|
||
|
Share price at grant date (in dollars)
|
|
|
||
|
Dividend yield
|
|
|
||
|
Expected volatility (A)
|
|
|
||
|
Risk-free interest rate (US government bond yield)
|
|
|
||
|
Model used
|
Monte Carlo
|
Monte Carlo
|
|
Performance-Based RSU
|
Restricted Stock Units
|
||||||||
|
Potential Shares
|
Weighted-Average
Grant-Date Fair
Value per Share
|
Potential Shares
|
Weighted-Average
Grant-Date Fair
Value per Share
|
||||||
|
At January 1, 2024
|
|
$
|
|
$
|
|||||
|
Granted (A)
|
|
$
|
|
$
|
|||||
|
Over-performance (B)
|
|
$
|
|
$
|
|||||
|
Vested
|
(
|
$
|
(
|
$
|
|||||
|
Forfeited (C)
|
(
|
$
|
(
|
$
|
|||||
|
At December 31, 2024
|
|
$
|
|
$
|
|||||
|
Name
|
Age
|
Position
|
Date of Appointment
|
Current Term
|
||||
|
Jean-Christophe Deslarzes
|
61
|
Chairman
|
May 11, 2021
|
2024-2027
|
||||
|
Michiel Brandjes
|
70
|
Director
|
June 11, 2014
|
2023-2026
|
||||
|
John Ormerod
|
76
|
Director
|
June 11, 2014
|
2023-2026
|
||||
|
Lori A. Walker
|
67
|
Director
|
June 11, 2014
|
2022-2025
|
||||
|
Martha Brooks
|
65
|
Director
|
June 15, 2016
|
2022-2025
|
||||
|
Jean-Marc Germain
|
59
|
Director and also CEO
|
June 15, 2016
|
2023-2026
|
||||
|
Isabelle Boccon-Gibod
|
56
|
Director
|
May 11, 2021
|
2024-2027
|
||||
|
Jean-Philippe Puig
|
64
|
Director
|
May 11, 2021
|
2024-2027
|
||||
|
Jean-François Verdier
|
61
|
Employee Director
|
December 1, 2021
|
2024-2027
|
||||
|
Wiebke Weiler
|
40
|
Employee Director
|
December 1, 2021
|
2024-2027
|
||||
|
Emmanuel Blot
|
39
|
Director
|
June 10, 2022
|
2022-2025
|
|
Name
|
Age
|
Title
|
|||
|
Jean-Marc Germain
|
59
|
Chief Executive Officer
|
|||
|
Ingrid Joerg
|
55
|
Executive Vice President and Chief Operating Officer
President, Packaging & Automotive Rolled Products business unit
|
|||
|
Jack Guo
|
46
|
Senior Vice President and Chief Financial Officer
|
|||
|
Philippe Hoffmann
|
59
|
President, Aerospace & Transportation business unit
|
|||
|
Alexandra Bendler
|
51
|
President, Automotive Structures & Industry business unit
|
|||
|
Ludovic Piquier
|
52
|
Senior Vice President Manufacturing Excellence and Chief Technical Officer
|
|||
|
Philip Ryan Jurkovic
|
53
|
Senior Vice President and Chief Human Resources Officer
|
|||
|
Nicolas Brun
|
58
|
Senior Vice President, Public Affairs, Communications and Sustainability
|
|||
|
Marcus Becker
|
49
|
Senior Vice President & Chief Procurement Officer
|
|||
|
Niklaus Schild
|
46
|
Senior Vice President, Chief Information Officer and Chief Digital Officer
|
|||
|
Stephen Walters
|
60
|
Senior Vice President, Group General Counsel
(1)
|
|||
|
Plan Category
|
Number of securities to be issued
upon exercise of outstanding
options,warrants and rights (1) (a)
|
Weighted average exercise price of
outstanding options, warrants and
rights (b)
|
Number of securities remaining
available for future issuance under
equity compensation plans
(excluding securities reflected in
column a) (2)(c)
|
|
Equity compensation plans
approved by shareholders
|
3,448,644
|
N/A
|
6,000,000
|
|
Equity compensation plans not
approved by shareholders
|
N/A
|
N/A
|
N/A
|
|
Total
|
3,448,644
|
N/A
|
6,000,000
|
|
Name of beneficial owner of ordinary shares
|
Amount and
Nature of
Beneficial
Ownership
|
As a percentage
of the Total
Ordinary Shares
Outstanding
|
||||
|
5% Shareholders
|
||||||
|
T. Rowe Price Investment Management, Inc.
|
19,828,738
|
(1)
|
13.8%
|
|||
|
FMR LLC
|
14,643,776
|
(2)
|
10.2%
|
|||
|
Caisse des Dépôts (f/k/a Caisse des Dépôts et Consignations),
Bpifrance Participations S.A., Bpifrance S.A. (f/k/a BPI-Groupe),
EPIC Bpifrance (f/k/a EPIC BPI-Groupe)
|
12,593,903
|
(3)
|
8.8%
|
|||
|
BlackRock, Inc.
|
12,439,991
|
(4)
|
8.7%
|
|||
|
Directors
|
||||||
|
Michiel Brandjes
|
52,000
|
(5)
|
*
|
|||
|
John Ormerod
|
32,873
|
(6)
|
*
|
|||
|
Lori A. Walker
|
35,044
|
(7)
|
*
|
|||
|
Martha Brooks
|
169,741
|
(8)
|
*
|
|||
|
Isabelle Boccon-Gibod
|
21,000
|
(9)
|
*
|
|||
|
Jean-Christophe Deslarzes
|
26,368
|
(10)
|
*
|
|||
|
Jean-Philippe Puig
|
21,800
|
(11)
|
*
|
|||
|
Jean-François Verdier
|
41
|
(12)
|
*
|
|||
|
Wiebke Weiler
|
—
|
(13)
|
||||
|
Emmanuel Blot
|
—
|
(14)
|
||||
|
Named Executive Officers
|
||||||
|
Jean-Marc Germain
|
1,560,000
|
(15)
|
1.1%
|
|||
|
Jack Guo
|
65,925
|
(16)
|
*
|
|||
|
Ingrid Joerg
|
155,554
|
(17)
|
*
|
|||
|
Philippe Hoffmann
|
104,288
|
(18)
|
*
|
|||
|
Philip Ryan Jurkovic
|
129,180
|
(19)
|
*
|
|||
|
All executive officers and directors as a group (21 people)
|
2,654,137
|
(20)
|
1.8%
|
|
For the year ended December 31,
|
||||
|
( in thousands of U.S. Dollars)
|
2024
|
2023
|
||
|
Audit fees
|
6,738
|
5,040
|
||
|
Audit-related fees
|
253
|
114
|
||
|
Tax fees
|
293
|
316
|
||
|
All other fees
|
5
|
5
|
||
|
Total
(1)
|
7,289
|
5,475
|
||
|
3.1
|
|
|
4.1
|
|
|
4.2
|
|
|
4.3
|
|
|
4.4
|
|
|
4.5
|
|
|
4.6
|
|
|
4.7
|
|
|
4.8
|
|
|
4.9
|
|
|
10.1
|
|
|
10.2
|
|
|
10.3
|
|
|
10.4
|
|
|
10.5
|
|
|
10.6
|
|
|
10.7
|
|
|
10.8
|
|
|
10.9
|
|
|
10.10
|
|
|
10.11
|
|
|
10.12
|
|
|
10.13
|
|
|
10.14
|
|
|
10.15
|
|
|
10.16
|
|
|
10.17
|
|
|
10.18
|
|
|
10.19
|
|
|
10.20
|
|
|
10.21
|
|
|
10.22
|
|
|
10.23
|
|
|
10.24
|
|
|
10.25
|
|
|
10.26
|
|
|
10.27
|
|
|
10.28
|
|
|
10.29
|
|
|
10.30
|
|
|
10.31
|
|
|
10.32
|
|
|
10.33
|
|
|
10.34
|
|
|
10.35
|
|
|
10.36
|
|
|
10.37
|
|
|
10.38
|
|
|
10.39
|
|
|
10.40
|
|
|
10.41
|
|
|
10.42
|
|
|
10.43
|
|
|
10.44
|
|
|
10.45
|
|
|
10.46
|
|
|
10.47
|
|
|
10.48
|
|
|
10.49
|
|
|
10.50
|
|
|
10.51
|
|
|
10.52
|
|
|
10.53
|
|
|
10.54
|
|
|
10.55
|
|
|
10.56
|
|
|
10.57
|
|
|
10.58
|
|
|
10.59
|
|
|
10.60
|
|
|
10.61
|
|
|
10.62
|
|
|
10.63
|
|
|
10.64
|
|
|
10.65
|
|
|
10.66
|
|
|
10.67
|
|
|
10.68
|
|
10.69
|
|
|
10.70
|
|
|
10.71
|
|
|
10.72
|
|
|
10.73
|
|
|
10.74
|
|
|
10.75
|
|
|
10.76
|
|
|
10.77
|
|
|
14.1
|
|
|
19.1
|
|
|
21.1
|
|
|
23.1
|
|
|
31.1
|
|
|
31.2
|
|
|
32.1
|
|
|
32.2
|
|
|
97.1
|
|
|
101.INS
|
Inline XBRL Instance Document**
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document**
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document**
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document**
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document**
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document**
|
|
104.
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)**
|
|
|
Constellium SE
|
|
|
Date: February 28, 2025
|
By
|
/s/ Jean-Marc Germain
|
|
Jean-Marc Germain
|
||
|
Chief Executive Officer and Director
|
||
|
Name
|
Capacity
|
Date
|
||
|
/s/ Jean-Marc Germain
|
Chief Executive Officer and Director
|
February 28, 2025
|
||
|
Jean-Marc Germain
|
(Principal Executive Officer)
|
|||
|
/s/ Jack Guo
|
Senior Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
|
February 28, 2025
|
||
|
Jack Guo
|
||||
|
/s/ Jean-Christophe Deslarzes
|
Chairman
|
February 28, 2025
|
||
|
Jean-Christophe Deslarzes
|
||||
|
/s/ Michiel Brandjes
|
Director
|
February 28, 2025
|
||
|
Michiel Brandjes
|
||||
|
/s/ John Ormerod
|
Director
|
February 28, 2025
|
||
|
John Ormerod
|
||||
|
/s/ Lori A. Walker
|
Director
|
February 28, 2025
|
||
|
Lori A. Walker
|
||||
|
/s/ Martha Brooks
|
Director
|
February 28, 2025
|
||
|
Martha Brooks
|
||||
|
/s/ Isabelle Boccon-Gibod
|
Director
|
February 28, 2025
|
||
|
Isabelle Boccon-Gibod
|
||||
|
/s/ Jean-Philippe Puig
|
Director
|
February 28, 2025
|
||
|
Jean-Philippe Puig
|
||||
|
/s/ Jean-François Verdier
|
Employee Director
|
February 28, 2025
|
||
|
Jean-François Verdier
|
||||
|
/s/ Wiebke Weiler
|
Employee Director
|
February 28, 2025
|
||
|
Wiebke Weiler
|
||||
|
/s/ Emmanuel Blot
|
Director
|
February 28, 2025
|
||
|
Emmanuel Blot
|
||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|